
Sign up to save your podcasts
Or


The Filtrate:
Matt Sparks
Jennie Lin
Samira Farouk
Joel Topf
Swapnil Hiremath
And two special guests:
Dawn J. Caster, Assistant Professor at University of Louisville
Alfred Kim, Assistant Professor of Medicine at Washington University (Twitter)
Show Notes:
NephJC coverage of the trial: The Bliss trial
In the NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa2001180
Turtles all the way down: https://en.wikipedia.org/wiki/Turtles_all_the_way_down
Nature previews Nephrology on BAFF: https://www.nature.com/articles/nri844
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial: https://pubmed.ncbi.nlm.nih.gov/29563108/
BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration: https://clinicaltrials.gov/ct2/show/NCT02062684
Guideline for naming monoclonal drugs: https://www.antibodysociety.org/wordpress/wp-content/uploads/2017/07/INN-2017-Reference-20.pdf
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group: https://pubmed.ncbi.nlm.nih.gov/9541091/
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis https://pubmed.ncbi.nlm.nih.gov/25757867/
A Day In The Life Of Dr. Anthony Fauci: https://www.huffpost.com/entry/anthony-fauci-fighting-covid-19_n_5fc7fed7c5b61bea2b14e3ee
MC Arbatin MD FPCP FPSN @mcamd: the glomerulus tree: https://twitter.com/mcamd/status/1337744822543605760
finished product: https://twitter.com/mcamd/status/1338429211963322371
By NephJC Team4.9
166166 ratings
The Filtrate:
Matt Sparks
Jennie Lin
Samira Farouk
Joel Topf
Swapnil Hiremath
And two special guests:
Dawn J. Caster, Assistant Professor at University of Louisville
Alfred Kim, Assistant Professor of Medicine at Washington University (Twitter)
Show Notes:
NephJC coverage of the trial: The Bliss trial
In the NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa2001180
Turtles all the way down: https://en.wikipedia.org/wiki/Turtles_all_the_way_down
Nature previews Nephrology on BAFF: https://www.nature.com/articles/nri844
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial: https://pubmed.ncbi.nlm.nih.gov/29563108/
BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration: https://clinicaltrials.gov/ct2/show/NCT02062684
Guideline for naming monoclonal drugs: https://www.antibodysociety.org/wordpress/wp-content/uploads/2017/07/INN-2017-Reference-20.pdf
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group: https://pubmed.ncbi.nlm.nih.gov/9541091/
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis https://pubmed.ncbi.nlm.nih.gov/25757867/
A Day In The Life Of Dr. Anthony Fauci: https://www.huffpost.com/entry/anthony-fauci-fighting-covid-19_n_5fc7fed7c5b61bea2b14e3ee
MC Arbatin MD FPCP FPSN @mcamd: the glomerulus tree: https://twitter.com/mcamd/status/1337744822543605760
finished product: https://twitter.com/mcamd/status/1338429211963322371

137 Listeners

319 Listeners

498 Listeners

3,339 Listeners

14 Listeners

1,151 Listeners

191 Listeners

704 Listeners

513 Listeners

367 Listeners

249 Listeners

431 Listeners

372 Listeners

137 Listeners

233 Listeners